Defensive medicine: implications for clinical practice, patients and healthcare policy

Acta Clin Belg. 2015 Dec;70(6):396-7. doi: 10.1179/2295333715Y.0000000037. Epub 2015 Jul 3.

Authors

T Vandersteegen¹, W Marneffe, D Vandijck

Affiliation

¹ 1 Faculty of Applied Economics, Hasselt University , Belgium.

PMID: 26139070
DOI: 10.1179/2295333715Y.0000000037

No abstract available

Keywords: Adverse event; Defensive medicine; Healthcare costs; Non-disclosure; Quality of care.

MeSH terms

Defensive Medicine*
Delivery of Health Care
Health Policy